Achmea Investment Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,822	Closed	-$1M	–	313
2025 Q3	$1M	Hold	3,822	–	–	0.01%	286
2025 Q2	$836K	Hold	3,822	–	–	0.01%	315
2025 Q1	$856K	Buy	3,822 +1,113	+41%	+$307K	0.01%	338
2024 Q4	$887K	Sell	2,709 -1,945	-42%	-$612K	0.01%	364
2024 Q3	$1.4M	Sell	4,654 -2,602	-36%	-$797K	0.02%	339
2024 Q2	$2.39M	Sell	7,256 -3,804	-34%	-$1.34M	0.04%	299
2024 Q1	$4.38M	Hold	11,060	–	–	0.08%	236
2023 Q4	$3.9M	Sell	11,060 -326	-3%	-$115K	0.08%	245
2023 Q3	$4.27M	Buy	11,386 +3,824	+51%	+$1.48M	0.09%	227
2023 Q2	$2.89M	Buy	7,562 +4,300	+132%	+$1.54M	0.06%	300
2023 Q1	$1.13M	Hold	3,262	–	–	0.03%	379
2022 Q4	$719K	Sell	3,262 -2,698	-45%	-$639K	0.02%	442
2022 Q3	$1.47M	Sell	5,960 -4,433	-43%	-$1.35M	0.05%	328
2022 Q2	$3.14M	Sell	10,393 -7,036	-40%	-$2.29M	0.1%	222
2022 Q1	$7.16M	Buy	+17,429	New	+$6.82M	0.19%	127
2021 Q4	–	Sell	-30,231	Closed	-$12.8M	–	669
2021 Q3	$12.8M	Sell	30,231 -193	-0.6%	-$81.4K	0.39%	51
2021 Q2	$10.9M	Buy	30,424 +879	+3%	+$290K	0.37%	56
2021 Q1	$8.32M	Sell	29,545 -1,610	-5%	-$461K	0.29%	93
2020 Q4	$8.83M	Buy	31,155 +2,706	+10%	+$759K	0.32%	79
2020 Q3	$7.82M	Buy	+28,449	New	+$7.53M	0.33%	79